GTS Securities’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-81,201
Closed -$1.19M – 2100
2024
Q3
$1.19M Buy
81,201
+47,814
+143% +$666K ﹤0.01% 2000
2024
Q2
$482K Sell
33,387
-47,715
-59% -$762K ﹤0.01% 2732
2024
Q1
$1.32M Sell
81,102
-43,556
-35% -$681K ﹤0.01% 1782
2023
Q4
$1.86M Buy
124,658
+62,915
+102% +$713K ﹤0.01% 1705
2023
Q3
$694K Buy
61,743
+5,856
+10% +$68K ﹤0.01% 2298
2023
Q2
$562K Buy
+55,887
New +$519K 0.02% 614

Other funds holding ELAN

GTS Securities's ELAN Position: Q4 2024 in Review

GTS Securities sold out of Elanco Animal Health (ELAN) in Q4 2024, closing a stake of 81,201 shares — an estimated $1.19M sold.

GTS Securities first reported a position in ELAN in Q2 2023 and held it in 6 quarters. The position peaked at $1.86M in Q4 2023. 394 funds tracked by Wall St. Rank hold ELAN as of Q4 2024.

  • GTS Securities reported no remaining Elanco Animal Health position as of Q4 2024 after selling out during the quarter.
  • GTS Securities sold 81,201 Elanco Animal Health shares in Q4 2024, an estimated $1.19M.
  • GTS Securities first reported a position in Elanco Animal Health in Q2 2023 and held it in 6 quarters.
  • GTS Securities's Elanco Animal Health position peaked at $1.86M in Q4 2023.
  • 394 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2024.

Based on GTS Securities's 13F filing for Q4 2024, filed 18 Feb 2025.